# Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy

> **NCT06631352** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Hepatopancreaticobiliary (HPB) Malignancy
- Gall Bladder Cancer
- Bile Duct Cancer
- Pancreatoduodenectomy
- Hepatectomy

## Interventions

- **OTHER:** Hepatopancreatoduodenectomy

## Key facts

- **NCT ID:** NCT06631352
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06631352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06631352, "Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06631352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*